↓ Skip to main content

Effect of the molecular targeted drug, erlotinib, against endometrial cancer expressing high levels of epidermal growth factor receptor

Overview of attention for article published in BMC Cancer, December 2015
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (55th percentile)
  • Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

patent
1 patent

Citations

dimensions_citation
19 Dimensions

Readers on

mendeley
23 Mendeley